 |
|
|
| |
Letermovir for CMV Suppression Improves
Immunologic and Functional Aging Outcomes in Treated HIV
|
| |
| |
CROI 2025 SF March 9-12
Sara Gianella, Kristine Erlandson, Douglas W. Kitch, Shirley Qiu, Yoshinori Fukazawa, Milenka V. Meneses, Scott Letendre, Michael P. Dube, Lawrence Fox, John R. Koethe, Priscilla Hsue, Davey M. Smith, Michael L. Freeman, and Peter W. Hunt
for the ACTG A5383 (ELICIT) Trial Team
|
| |
|
|
|
|
|
